Abstract
This cohort study examines patterns of bone-modifying agent use from 2013 to 2024 among men with metastatic castration-resistant prostate cancer.
| Original language | English (US) |
|---|---|
| Article number | e2620084 |
| Journal | JAMA Network Open |
| Volume | 9 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 24 2026 |
Bibliographical note
Publisher Copyright:© 2026 Ozay ZI et al.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Bone-Modifying Agents in Metastatic Castration-Resistant Prostate Cancer'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS